Huma Fatima

1.1k total citations
31 papers, 587 citations indexed

About

Huma Fatima is a scholar working on Surgery, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huma Fatima has authored 31 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Nephrology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huma Fatima's work include Renal Diseases and Glomerulopathies (6 papers), Xenotransplantation and immune response (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Huma Fatima is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Xenotransplantation and immune response (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Huma Fatima collaborates with scholars based in United States, Saudi Arabia and Pakistan. Huma Fatima's co-authors include Denyse Thornley‐Brown, Leah J. Leisch, Gaurav Jain, Marcus J. Moeller, Haichun Yang, Agnes B. Fogo, Charles E. Alpers, Bart Smeets, Eric Wallace and Vivette D. D’Agati and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Kidney International.

In The Last Decade

Huma Fatima

28 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huma Fatima United States 13 218 124 95 94 92 31 587
Suzanne Meleg-Smith United States 13 148 0.7× 62 0.5× 77 0.8× 91 1.0× 116 1.3× 22 565
Katherine Bennett Canada 7 267 1.2× 354 2.9× 8 0.1× 28 0.3× 254 2.8× 10 950
Yasushi Koitabashi Japan 13 208 1.0× 38 0.3× 4 0.0× 13 0.1× 79 0.9× 23 434
Beng Fuh United States 11 68 0.3× 40 0.3× 7 0.1× 15 0.2× 98 1.1× 30 512
Amelia P. Bailey United States 15 53 0.2× 58 0.5× 2 0.0× 26 0.3× 117 1.3× 30 687
O Sakai Japan 10 343 1.6× 150 1.2× 2 0.0× 22 0.2× 134 1.5× 27 566
Yukinao Sakai Japan 15 136 0.6× 78 0.6× 2 0.0× 16 0.2× 214 2.3× 62 528
Collette McCourt United Kingdom 9 23 0.1× 74 0.6× 3 0.0× 35 0.4× 158 1.7× 27 1.0k
Basset El Essawy United States 12 62 0.3× 200 1.6× 2 0.0× 34 0.4× 171 1.9× 17 781
Muammer Kara Türkiye 15 56 0.3× 155 1.3× 2 0.0× 39 0.4× 79 0.9× 37 654

Countries citing papers authored by Huma Fatima

Since Specialization
Citations

This map shows the geographic impact of Huma Fatima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huma Fatima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huma Fatima more than expected).

Fields of papers citing papers by Huma Fatima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huma Fatima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huma Fatima. The network helps show where Huma Fatima may publish in the future.

Co-authorship network of co-authors of Huma Fatima

This figure shows the co-authorship network connecting the top 25 collaborators of Huma Fatima. A scholar is included among the top collaborators of Huma Fatima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huma Fatima. Huma Fatima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Latif, Muhammad, Asmat Ullah Khan, Huma Fatima, et al.. (2025). Leading report on the molecular prevalence of emerging pathogens Hepatozoon sp. and Lankesterella sp. in the blood samples of seven wild lizard species. Scientific Reports. 15(1). 9014–9014.
3.
Fatima, Huma, Isam‐Eldin Eltoum, Vineeta Kumar, Douglas J. Anderson, & Jayme E. Locke. (2025). Immunofluorescence and Electron Microscopy in Genetically Engineered Pig-to-Human Kidney Xenotransplantation: A Case Report. American Journal of Kidney Diseases. 86(4). 563–569. 1 indexed citations
4.
Fatima, Huma, et al.. (2024). The underdiagnosed kidney burden of Fabry disease in females. 8(4). 394–405. 1 indexed citations
5.
Judd, Eric, Vineeta Kumar, Paige M. Porrett, et al.. (2024). Physiologic homeostasis after pig-to-human kidney xenotransplantation. Kidney International. 105(5). 971–979. 27 indexed citations
6.
Fatima, Huma, Vineeta Kumar, Douglas J. Anderson, et al.. (2024). C5 inhibition with eculizumab prevents thrombotic microangiopathy in a case series of pig-to-human kidney xenotransplantation. Journal of Clinical Investigation. 134(5). 20 indexed citations
7.
Kumar, Parveen, Zhengqin Yang, Huma Fatima, & Tanecia Mitchell. (2024). Hydroxyproline increases inflammation and Uropathogenic E. coli (UPEC) infection in female rats. Scientific Reports. 14(1). 22237–22237. 2 indexed citations
8.
Fatima, Huma, et al.. (2022). Lupus nephritis correlates with B cell interferon-β, anti-Smith, and anti-DNA: a retrospective study. Arthritis Research & Therapy. 24(1). 87–87. 12 indexed citations
9.
Shelton, Brittany A., Deirdre Sawinski, Paul A. MacLennan, et al.. (2022). Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study. EClinicalMedicine. 53. 101653–101653. 2 indexed citations
10.
Chahed, Samah, Yi Zhao, Ji Yeon Kim, et al.. (2022). Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin. Cell Communication and Signaling. 20(1). 76–76. 12 indexed citations
11.
Newell‐Fugate, Annie E., et al.. (2022). Aromatase inhibition increases blood pressure and markers of renal injury in female rats. American Journal of Physiology-Renal Physiology. 323(3). F349–F360. 5 indexed citations
12.
Nasr, Samih H., Surendra Dasari, Jason D. Theis, et al.. (2021). Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft. Kidney Medicine. 3(3). 433–437. 1 indexed citations
13.
Hong, Huixian, Casey D. Morrow, Jeremy B. Foote, et al.. (2021). Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice. Arthritis & Rheumatology. 74(4). 634–640. 9 indexed citations
14.
Bettaieb, Ahmed, Shinichiro Koike, Samah Chahed, et al.. (2017). Podocyte‐specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. FEBS Journal. 284(13). 1970–1986. 27 indexed citations
15.
Salam, Abdus, et al.. (2017). Rare Presentation of a Posterior Mediastinal Cystic Schwannoma as a Large Pleural Effusion. Cureus. 9(8). e1558–e1558. 6 indexed citations
16.
Inman, Melissa, et al.. (2015). Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis. Clinical Kidney Journal. 8(4). 445–448. 23 indexed citations
17.
Wallace, Eric, et al.. (2015). Appendiceal tissue confirmation of Fabry’s disease. Kidney International. 88(2). 417–417. 1 indexed citations
18.
Wallace, Eric, et al.. (2013). Dasatinib-Induced Nephrotic-Range Proteinuria. American Journal of Kidney Diseases. 61(6). 1026–1031. 33 indexed citations
19.
Jain, Gaurav, et al.. (2012). AKI Associated with Synthetic Cannabinoids. Clinical Journal of the American Society of Nephrology. 8(4). 523–526. 115 indexed citations
20.
Fatima, Huma, Marcus J. Moeller, Bart Smeets, et al.. (2012). Parietal Epithelial Cell Activation Marker in Early Recurrence of FSGS in the Transplant. Clinical Journal of the American Society of Nephrology. 7(11). 1852–1858. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026